Tag: LJX Pharmaceutical
Income indicators and risks for pharma IPOs
How income indicators and sales expenses impact risks in pharmaceutical IPOs under regulatory scrutiny
How income indicators and sales expenses impact risks in pharmaceutical IPOs under regulatory scrutiny
While stock exchanges lower barriers to atrract emerging sector issuers, regulators focus on accountability of listco and intermediaries at the top corporate level